Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Portola Pharmaceuticals Inc Announces Closing of Initial Public Offering and Over-Allotment Option Exercise


Tuesday, 28 May 2013 06:33pm EDT 

Portola Pharmaceuticals Inc announced today the closing of its initial public offering of 9,686,171 shares of its common stock at a price to the public of $14.50 per share. All of the 9,686,171 shares are being offered by Portola and include 1,263,413 shares issued pursuant to the over-allotment option granted to the underwriters, which was exercised in full. Morgan Stanley and Credit Suisse acted as the joint book-running managers for the offering. Cowen and Company, William Blair and Sanford C. Bernstein acted as co-managers. 

Company Quote

29.56
 --
17 Dec 2014